PTK2 and head and neck squamous cell carcinoma: As FAK has an established critical role in the process of cell motility, migration, and invasion20,40,41, we investigated whether treatment of HNSCC cells with the combination of BMS754807 and dasatinib could reduce motility, migration and/or invasion by using scratch assay and Boyden chamber assays.